COBRE in Stroke Recovery Administrative Supplement: Equipment

Information

  • Research Project
  • 10397250
  • ApplicationId
    10397250
  • Core Project Number
    P20GM109040
  • Full Project Number
    3P20GM109040-08S1
  • Serial Number
    109040
  • FOA Number
    PA-20-272
  • Sub Project Id
  • Project Start Date
    6/2/2014 - 10 years ago
  • Project End Date
    3/31/2024 - 10 months ago
  • Program Officer Name
    GAO, HONGWEI
  • Budget Start Date
    9/1/2021 - 3 years ago
  • Budget End Date
    3/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    08
  • Suffix
    S1
  • Award Notice Date
    9/1/2021 - 3 years ago

COBRE in Stroke Recovery Administrative Supplement: Equipment

PROJECT SUMMARY / ABSTRACT The Organizing Concept of the parent Phase II COBRE in Stroke Recovery is that better understanding of the experience-dependent nature of neural plasticity allows us to investigate and exploit inherent neural recovery processes, develop and translate novel mechanism-based interventional strategies, and ultimately improve the function and quality of life of individuals recovering from stroke. And Overall Specific Aim 2 focuses on strengthening innovative scientific cores that support/advance stroke recovery research ? such as the Brain Stimulation and Neuroimaging Cores. Transcranial magnetic stimulation-functional magnetic resonance imaging (TMS-fMRI) is a technology initially developed over 20 years ago by investigators of the COBRE in Stroke Recovery. This technique established the utility of TMS beyond its application as an intervention by using it to interrogate neural network function by ?perturbing? or ?probing? neurocircuits with TMS and observing causal whole-brain responses with concurrent fMRI. The existing technology used by COBRE investigators has significant limitations. In direct alignment with the Organizing Concept and Overall Specific Aim above, we propose to acquire the first-in-class, state-of-the art interleaved MagVenture TMS-fMRI Research System with MR-compatible neuronavigation to advance precision rehabilitation for stroke recovery. We will integrate the system with our existing research-dedicated Siemens 3T Prisma MRI. The new system will provide: 1. Greater flexibility in targeted cortical regions: positioning of the TMS coil in our 12-channel birdcage coil is substantially hindered. The new system uses two ultraslim 7-channel array head receiving coils enabling flexible and reliable targeting of all cortical regions. 2. Improved quality of fMRI data: the distance between the participant?s head and the birdcage coil results in far lower signal to noise ratio (SNR). The new system?s surface arrays show a five- fold SNR increase over the traditional bird cage coil. Further, artifact in acquired MR images from the TMS coil is avoided. 3. Capability for in-scanner neuronavigation: we have no capability for in-scanner tracking of the TMS coil placement on the head. This is especially problematic as small shifts in coil placement or angle and/or head movement can result in TMS being delivered off target and at variable doses. The neuronavigation available in the MagVenture system will substantially improve data quality. 4. Capability for in-scanner repetitive TMS (rTMS): our existing system does not have cooling capacity for the TMS coil. As such, we can only deliver single pulses of TMS and not rTMS. The proposed system has an air-cooled coil to allow us to directly test rTMS protocols in the scanner, including high-demand stimulation patterns, without overheating. This will allow COBRE investigators to test the near-immediate, circuit-level effects of novel rTMS dosing and pulse sequences such as theta burst. The methodological sophistication of the MagVenture system promises to substantially and expeditiously advance and personalize neurorehabilitation for chronic stroke by allowing us to visualize and perturb the neural circuits of individual stroke survivors during a range of neuromodulation interventions.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    P20
  • Administering IC
    GM
  • Application Type
    3
  • Direct Cost Amount
    250000
  • Indirect Cost Amount
    0
  • Total Cost
    250000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
    SCH ALLIED HEALTH PROFESSIONS
  • Funding ICs
    NIGMS:250000\
  • Funding Mechanism
    RESEARCH CENTERS
  • Study Section
  • Study Section Name
  • Organization Name
    MEDICAL UNIVERSITY OF SOUTH CAROLINA
  • Organization Department
    OTHER HEALTH PROFESSIONS
  • Organization DUNS
    183710748
  • Organization City
    CHARLESTON
  • Organization State
    SC
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    29407
  • Organization District
    UNITED STATES